Is IZO undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6
Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of IZO when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate IZO's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate IZO's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for IZO?
Key metric: As IZO is unprofitable and pre-revenue we use its Price-To-Book Ratio for relative valuation analysis.
The above table shows the Price to Book ratio for IZO. This is calculated by dividing IZO's market cap by their current
book value.
What is IZO's PB Ratio?
PB Ratio
-0.7x
Book
-CA$4.28m
Market Cap
CA$2.84m
IZO key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Book vs Industry: IZO has negative equity and a Price-To-Book Ratio (-0.7x) compared to the North American Medical Equipment industry average (2.6x).
Price to Book Ratio vs Fair Ratio
What is IZO's PB Ratio
compared to its
Fair PB Ratio?
This is the expected PB Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
IZO PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio
-0.7x
Fair PB Ratio
n/a
Price-To-Book vs Fair Ratio: Insufficient data to calculate IZO's Price-To-Book Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.